Blastoma

Chemotherapy is a cancer treatment that uses drugs to destroy cancer cells in the body. However, one of the biggest challenges of chemotherapy is getting the drugs to reach the cancer cells in the brain. This is because the blood-brain barrier, which separates the blood vessels in the brain from…

Use of a novel skull-implantable ultrasound device was able to open the blood-brain barrier, which allowed for penetration of albumin-bound paclitaxel into critical regions of the brain in patients with glioblastoma, a dose-escalation phase I trial showed. Looking at low-intensity pulsed ultrasound with concomitant administration of intravenous microbubbles (LIPU-MB) with…

Health Penetrating the blood-brain barrier via pulses of ultrasound waves led to a three-fold increase in the concentration of a chemotherapy drug in people with the brain cancer glioblastoma multiforme By Soumya Sagar The blood-brain barrier acts as a roadblock against toxic substances and microorganisms CAROL & MIKE WERNER/SCIENCE PHOTO…

Just a moment... Read More

CUT AND RUN Published: 0:54, 21 Apr 2023A WOMAN who dumped her boyfriend because he had cancer is now running the London Marathon in his honour. Danielle Epstein, 32, said she ''felt like the most awful person" after leaving ex Jelle Fresen when he was diagnosed. 3 Danielle Epstein, 32,…

Just a moment... Read More

Glioblastoma is the most common type of brain tumor in adults. The disease is 100% fatal and there are no cures, making it the most aggressive type of cancer. Such a poor prognosis has motivated researchers and neurosurgeons to understand the biology of tumors with the goal of creating better…

Ruben Igielko-Herrlich, a veteran film marketing executive, died March 7 in Beverly Hills. He was 62 and had been fighting glioblastoma brain cancer for four years. He co-founded PropagandaGEM, a global entertainment marketing group, in 1991 with his friend and business partner Anders Granath. The company expanded to encompass 10…

Graphical Abstract. Credit: Cell Reports (2023). DOI: 10.1016/j.celrep.2023.112235 A new study of the aggressive brain cancer glioblastoma suggests that two specific cancer cell mutations may work together to help hide tumors from the immune system, offering a possible way to predict whether the tumors would respond to an emerging class…

Glioblastoma is an aggressive type of cancer that can occur in the brain or spinal cord. Patients with glioblastoma receive treatment that frequently leads to the unfortunate side effect of low white blood cell counts, i.e., severe and prolonged lymphopenia. It has been associated with worse survival, but its underlying…